lhrtimes.com
AOP Orphan announces European approvable opinion of its ultra-short acting beta blocker Rapibloc® - The Lahore Times
Ultra-short acting and highly cardio-selective beta blocker Rapibloc® (Landiolol) receives regulatory approval in Europe. Rapibloc® (Landiolol) allows rapid control of heart rate with a...